AETHLON MEDICAL, INC. Other Comprehensive Income (Loss), Tax
AETHLON MEDICAL, INC. (AEMD) reported Other Comprehensive Income (Loss), Tax of $1.55 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossTax · last filed 2026-08-13
- AETHLON MEDICAL, INC. other comprehensive income (loss), tax for the quarter ending 2026-06-30 was $1.55M, a 12.05% decline year-over-year.
- AETHLON MEDICAL, INC. other comprehensive income (loss), tax for the quarter ending 2025-12-31 was $2.02M, a 14.36% increase year-over-year.
- AETHLON MEDICAL, INC. other comprehensive income (loss), tax for the quarter ending 2025-09-30 was $1.49M, a 46.81% decline year-over-year.
- AETHLON MEDICAL, INC. other comprehensive income (loss), tax for the quarter ending 2025-06-30 was $1.77M, a 31.30% decline year-over-year.
- AETHLON MEDICAL, INC. other comprehensive income (loss), tax for fiscal 2024 was $799.00, a 86.99% decline from fiscal 2023.
- AETHLON MEDICAL, INC. other comprehensive income (loss), tax for fiscal 2023 was $6.14K.
- AETHLON MEDICAL, INC. other comprehensive income (loss), tax for fiscal 2022 was $0.00.
| Period end | Other Comprehensive Income (Loss), Tax 3 month | Other Comprehensive Income (Loss), Tax 6 month | Other Comprehensive Income (Loss), Tax 9 month | Other Comprehensive Income (Loss), Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.55M 10-Q · filed 2026-08-13 | |||
| 2025-12-31 | $2.02M 10-Q · filed 2026-02-12 | $3.51M derived: sum of 2 quarters · filed 2026-02-12 | $5.28M 10-Q · filed 2026-02-12 | |
| 2025-09-30 | $1.49M 10-Q · filed 2025-11-12 | $3.26M 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | $1.77M 10-Q · filed 2026-08-13 | |||
| 2024-12-31 | $1.77M 10-Q · filed 2026-02-12 | $4.57M derived: sum of 2 quarters · filed 2026-02-12 | $7.14M 10-Q · filed 2026-02-12 | -$2.63M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-09-30 | $2.80M 10-Q · filed 2025-11-12 | $5.38M 10-Q · filed 2025-11-12 | -$4.40M derived: sum of 3 quarters · filed 2025-11-12 | -$943.82K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $2.57M 10-Q · filed 2025-08-13 | -$7.21M derived: sum of 2 quarters · filed 2025-08-13 | -$3.75M derived: sum of 3 quarters · filed 2025-08-13 | -$710.10K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | -$9.78M derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-27 | -$6.32M derived: sum of 2 quarters · filed 2025-02-12 | -$3.28M derived: sum of 3 quarters · filed 2025-02-12 | $799.00 10-K · filed 2024-06-27 |
| 2023-12-31 | $3.46M 10-Q · filed 2025-02-12 | $6.50M derived: sum of 2 quarters · filed 2025-02-12 | $9.78M 10-Q · filed 2025-02-12 | $221.52K derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-09-30 | $3.04M 10-Q · filed 2024-11-13 | $6.32M 10-Q · filed 2024-11-13 | -$3.24M derived: sum of 3 quarters · filed 2024-11-13 | -$386.89K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $3.28M 10-Q · filed 2024-08-14 | -$6.27M derived: sum of 2 quarters · filed 2024-08-14 | -$3.42M derived: sum of 3 quarters · filed 2024-08-14 | $383.65K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$9.56M derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-27 | -$6.71M derived: sum of 2 quarters · filed 2024-06-27 | -$2.90M derived: sum of 3 quarters · filed 2024-06-27 | $6.14K 10-K · filed 2024-06-27 |
| 2022-12-31 | $2.85M 10-Q · filed 2024-02-14 | $6.66M derived: sum of 2 quarters · filed 2024-02-14 | $9.56M 10-Q · filed 2024-02-14 | |
| 2022-09-30 | $3.81M 10-Q · filed 2023-11-14 | $6.72M 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $2.91M 10-Q · filed 2023-08-10 | |||
| 2022-03-31 | $0.00 10-K · filed 2023-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |